Download Citation
Article Source:
Cardiometabolic Risks of Blonanserin and Perospirone in the Management of Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Kishi T,
Matsuda Y,
Iwata N
(2014)
Cardiometabolic Risks of Blonanserin and Perospirone in the Management of Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
PLOS ONE 9(2): e88049.
https://doi.org/10.1371/journal.pone.0088049